These data suggest that although radiation therapy fails to increase the number of CD103+ DCs migrating from the tumor, treatment does increase the proportion of tumor-migratory CD103+ DCs co-expressing CD40 and CD80 in the TdLN relative to untreated controls. This evidence concerns the gene ITGAE and neoplasm.